Phase 1 Study of Ixazomib, an Investigational Proteasome Inhibitor, in Advanced Non-Hematologic Malignancies
Investigational New Drugs - Netherlands
doi 10.1007/s10637-015-0230-x
Full Text
Open PDFAbstract
Available in full text
Date
March 18, 2015
Authors
Publisher
Springer Science and Business Media LLC